Biotech Values

[mcbio]

As long as the underlying company's balance sheet and revenues are in a currency other than dollars, how do you avoid currency risk no matter which instrument yo select?

Well, if you settle the trade in dollars, aren't you effectively hedging the underlying currency risk? Also, despite the fact that GLPG.BR has some revenues, they are effectively a development stage biotech whose success will be tied to the successful development of its pipeline in the intermediate-term and not tied to revenues per se.